Terms: = Germ cell tumor AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx AND Diagnosis
6 results:
1. Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities.
Ahirwar K; Kumar A; Srivastava N; Saraf SA; Shukla R
Int J Biol Macromol; 2024 May; 266(Pt 1):131048. PubMed ID: 38522697
[TBL] [Abstract] [Full Text] [Related]
2. Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib.
Cabezas-Camarero S; García-Barberán V; Pérez-Alfayate R; Gómez Del Pulgar ME; Cabrera-Martin MN; Casado-Fariñas I; Pérez-Segura P
Oncologist; 2024 May; 29(5):377-383. PubMed ID: 38438322
[TBL] [Abstract] [Full Text] [Related]
3. smoothened loss is a characteristic of neuroendocrine prostate cancer.
Wang L; Li H; Li Z; Li M; Tang Q; Wu C; Lu Z
Prostate; 2021 Jun; 81(9):508-520. PubMed ID: 33955576
[TBL] [Abstract] [Full Text] [Related]
4. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
Paret C; Theruvath J; Russo A; Kron B; El Malki K; Lehmann N; Wingerter A; Neu MA; Gerhold-Ay A; Wagner W; Sommer C; Pietsch T; Seidmann L; Faber J
Oncotarget; 2016 Dec; 7(50):83378-83391. PubMed ID: 27825128
[TBL] [Abstract] [Full Text] [Related]
5. Rapid diagnosis of medulloblastoma molecular subgroups.
Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC
Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292
[TBL] [Abstract] [Full Text] [Related]
6. Vascular patterns of gestational trophoblastic tumors by color Doppler ultrasound.
Hsieh FJ; Wu CC; Lee CN; Chen TM; Chen CA; Chen FC; Chen CL; Hsieh CY
Cancer; 1994 Oct; 74(8):2361-5. PubMed ID: 7522951
[TBL] [Abstract] [Full Text] [Related]